Pediatric Drugs

Papers
(The H4-Index of Pediatric Drugs is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Alirocumab: Pediatric First Approval79
Safety of Ferric Carboxymaltose in Children: Report of a Case Series from Greece and Review of the Literature56
Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department42
Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives37
Treatment Options for Alopecia Areata in Children and Adolescents34
Managing Lupus Nephritis in Children and Adolescents33
Gentamicin Pharmacokinetics in Neonates Undergoing Therapeutic Hypothermia for Hypoxic Ischemic Encephalopathy32
Optimizing Drug Selection in Children with Multiple Sclerosis: What Do We Know and What Remains Unanswered?30
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study26
Perioperative Indications for Gabapentinoids in Pediatrics: A Narrative Review26
Acknowledgement to Referees25
Intranasal Analgesia in Preterm and Term Neonates25
Commercial Versus Compounded Preparations in Pediatric Ophthalmology22
Prevalence and Temporal Trends of Attention Deficit Hyperactivity Disorder Medication Fills During Pregnancy and Breastfeeding in Denmark21
A New Perspective on Drugs for Duchenne Muscular Dystrophy: Proposals for Better Respiratory Outcomes and Improved Regulatory Pathways21
New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products19
Low-Dose Remifentanil in Preterm Cesarean Section with General Anesthesia: A Randomized Controlled Trial18
Analysis of Risk Factors for Chloral Hydrate Sedative Failure with Initial Dose in Pediatric Patients: a Retrospective Analysis17
0.086850166320801